These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25753805)

  • 21. The ankle brachial index exhibits better association with cardiovascular outcomes than interarm systolic blood pressure difference in patients with type 2 diabetes.
    Lin LY; Hwu CM; Chu CH; Won JGS; Chen HS; Chang LH
    Medicine (Baltimore); 2019 May; 98(19):e15556. PubMed ID: 31083218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Charytan DM; Lewis EF; Desai AS; Weinrauch LA; Ivanovich P; Toto RD; Claggett B; Liu J; Hartley LH; Finn P; Singh AK; Levey AS; Pfeffer MA; McMurray JJ; Solomon SD
    Am J Kidney Dis; 2015 Sep; 66(3):429-40. PubMed ID: 25935581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of morning hypertension with chronic kidney disease progression and cardiovascular events in patients with chronic kidney disease and hypertension.
    Liu X; Li F; Zheng Z; Li G; Zhou H; Zhang T; Tang Y; Qin W
    Nutr Metab Cardiovasc Dis; 2022 Apr; 32(4):965-972. PubMed ID: 35172934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
    Charytan DM; Solomon SD; Ivanovich P; Remuzzi G; Cooper ME; McGill JB; Parving HH; Parfrey P; Singh AK; Burdmann EA; Levey AS; de Zeeuw D; Eckardt KU; McMurray JJV; Claggett B; Lewis EF; Pfeffer MA
    Am J Kidney Dis; 2017 Oct; 70(4):522-531. PubMed ID: 28599901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality: Individual Participant Data Meta-Analysis, Development and Validation of a Prognostic Algorithm: The INTERPRESS-IPD Collaboration.
    Clark CE; Warren FC; Boddy K; McDonagh STJ; Moore SF; Goddard J; Reed N; Turner M; Alzamora MT; Ramos Blanes R; Chuang SY; Criqui M; Dahl M; Engström G; Erbel R; Espeland M; Ferrucci L; Guerchet M; Hattersley A; Lahoz C; McClelland RL; McDermott MM; Price J; Stoffers HE; Wang JG; Westerink J; White J; Cloutier L; Taylor RS; Shore AC; McManus RJ; Aboyans V; Campbell JL
    Hypertension; 2021 Feb; 77(2):650-661. PubMed ID: 33342236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
    Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies.
    Minutolo R; Gabbai FB; Provenzano M; Chiodini P; Borrelli S; Garofalo C; Sasso FC; Santoro D; Bellizzi V; Conte G; De Nicola L
    Nephrol Dial Transplant; 2018 Nov; 33(11):1942-1949. PubMed ID: 29509925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.
    Azushima K; Wakui H; Uneda K; Haku S; Kobayashi R; Ohki K; Kinguchi S; Haruhara K; Fujikawa T; Toya Y; Umemura S; Tamura K
    Clin Exp Hypertens; 2017; 39(7):665-671. PubMed ID: 28635327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated Interarm Systolic Blood Pressure Difference Is Positively Associated with Increased Likelihood of Coronary Artery Disease.
    Li M; Fan F; Zhang Y; Ma W; Huo Y
    Int J Hypertens; 2021; 2021():5577957. PubMed ID: 34336266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes with a systolic blood pressure lower than 120 mmHg in older patients with high disease burden.
    Franco Palacios CR; Haugen EN; Thompson AM; Rasmussen RW; Goracke N; Goyal P
    Ren Fail; 2016 Oct; 38(9):1364-1369. PubMed ID: 27607547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.
    Papademetriou V; Lovato L; Tsioufis C; Cushman W; Applegate WB; Mottle A; Punthakee Z; Nylen E; Doumas M;
    Am J Nephrol; 2017; 45(2):136-145. PubMed ID: 27992863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing Agreement in the Level of Interarm Blood Pressure Readings of Adults in the Emergency Department (CALIBRATE Study).
    Bhutta ZA; Qureshi I; Shujauddin M; Thomas SA; Masood M; Dsouza LB; Iqbal N; Irfan FB; Pathan SA; Thomas SH
    Qatar Med J; 2020; 2020(1):14. PubMed ID: 32391250
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).
    Imai E; Ito S; Haneda M; Harada A; Kobayashi F; Yamasaki T; Makino H; Chan JC
    Nephrol Dial Transplant; 2016 Mar; 31(3):447-54. PubMed ID: 26152402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study.
    Usui T; Nagata M; Hata J; Mukai N; Hirakawa Y; Yoshida D; Kishimoto H; Kitazono T; Kiyohara Y; Ninomiya T
    J Atheroscler Thromb; 2017 Jul; 24(7):706-715. PubMed ID: 27840387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should pulse pressure become part of the Framingham risk score?
    Nawrot TS; Staessen JA; Thijs L; Fagard RH; Tikhonoff V; Wang JG; Franklin SS
    J Hum Hypertens; 2004 Apr; 18(4):279-86. PubMed ID: 15037878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease.
    Bolignano D; Lennartz S; Leonardis D; D'Arrigo G; Tripepi R; Emrich IE; Mallamaci F; Fliser D; Heine G; Zoccali C
    Kidney Int; 2015 Jul; 88(1):130-6. PubMed ID: 25692957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.